ONCOLife Articles
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife | 22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife | 23 March 2026
Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC
ONCOLife | 15 March 2026
Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife | 17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife | 20 March 2026
FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma
FDA & EMA | 20 March 2026
Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery
ONCOLife | 19 March 2026
Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV
ONCOLife | 15 March 2026
Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality
ONCOLife
9 March 2026
Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer
Clinical Trials
11 January 2026
Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer
ONCOLife
8 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials
24 December 2025
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer
ONCOLife
20 December 2025
FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer
FDA & EMA
18 December 2025
Platinum-Free PADCEV Plus Pembrolizumab Improves Survival in MI Bladder Cancer
Clinical Trials
18 December 2025
Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists
AI
12 December 2025
Less Toxic, More Effective: RW Evidence Supports Reduced Immunotherapy Dose in Melanoma
Clinical Trials
14 December 2025
Teclistamab plus Daratumumab Achieves an 83% Risk Reduction in R/R Multiple Myeloma
Clinical Trials
10 December 2025
FDA Approves AKEEGA for BRCA2+ Prostate Cancer as the First Precision Therapy
FDA & EMA
12 December 2025
Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer
Clinical Trials
9 December 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
